Investigating the role of a protein in melanoma development and progression

Role of sirtuin 6 in melanoma development and progression

NIH-funded research Wm S. Middleton Memorial Veterans Hosp · NIH-11183334

This study is looking at how a protein called SIRT6 affects the growth and spread of melanoma, a serious skin cancer, to find new ways to treat it better for patients.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionWm S. Middleton Memorial Veterans Hosp NIH-funded
Lab location1 site (Madison, United States)
Project IDNIH-11183334 on NIH RePORTER

What this research studies

This research focuses on understanding how the protein sirtuin 6 (SIRT6) influences the growth and spread of melanoma, a serious skin cancer. Researchers are examining the mechanisms by which SIRT6 contributes to melanoma's resistance to existing treatments and its role in promoting cancer cell proliferation. By using both laboratory and animal models, the study aims to identify new therapeutic strategies that target SIRT6 to improve melanoma management. The findings could lead to the development of innovative treatments that are more effective against this aggressive cancer.

Who could benefit from this research

Good fit: Ideal candidates for this research are patients diagnosed with malignant melanoma, particularly those who have experienced treatment resistance.

Not a fit: Patients with non-melanoma skin cancers or those without a diagnosis of melanoma may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatment options for melanoma patients, potentially overcoming drug resistance and improving survival rates.

How similar studies have performed: Previous research has shown promising results in targeting sirtuins for cancer treatment, indicating that this approach may be effective.

Where this research is happening

Madison, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.